SCHEMBL661896

SCHEMBL661896

CC1(C)OB(c2cnn(C3CCN(C(=O)C4CC4)CC3)c2)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.41
USP30 Q70CQ3 1/20 0.37
LRRK2 Q5S007 4/20 0.36
ALDH1A1 P00352 4/20 0.34
JAK3 P52333 3/20 0.34
EGFR P00533 1/20 0.34
LCK P06239 1/20 0.34
BTK Q06187 1/20 0.34
DDB1 Q16531 1/20 0.34
CRBN Q96SW2 1/20 0.34
JAK1 P23458 2/20 0.33
TYK2 P29597 2/20 0.33
JAK2 O60674 1/20 0.33
HPGD P15428 1/20 0.33
MAP3K7 O43318 2/20 0.32
TAB1 Q15750 2/20 0.32
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32
KDM5A P29375 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22086365 0.89 FFAR1 (0.42) FFAR1USP30LRRK2JAK3JAK1
SCHEMBL658691 0.89 FFAR1 (0.42) FFAR1JAK3JAK1TYK2MAP3K7
SCHEMBL320321 0.89 FFAR1 (0.42) FFAR1USP30JAK3DDB1CRBN
SCHEMBL2750019 0.88 FFAR1 (0.41) FFAR1USP30JAK3DDB1CRBN
SCHEMBL21808282 0.86 FFAR1 (0.40) FFAR1USP30LRRK2JAK3DDB1
SCHEMBL2329051 0.86 JAK1 (0.43) FFAR1USP30JAK3DDB1CRBN
SCHEMBL23211127 0.85 FFAR1 (0.41) FFAR1USP30JAK3DDB1CRBN
SCHEMBL16342703 0.85 FFAR1 (0.41) FFAR1USP30JAK3DDB1CRBN
SCHEMBL23211118 0.85 FFAR1 (0.41) FFAR1USP30JAK3DDB1CRBN
SCHEMBL12105464 0.85 GPR119 (0.39) FFAR1USP30JAK3DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 FFAR1 2193/4885USP30 2453/4885LRRK2 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.